Antimicrobial γ-AApeptides (WO2013112548): a patent evaluation

Abstract

The patent application WO2013112548 claims a new class of peptidomimetics – γ-AApeptides with potent and broad-spectrum antimicrobial activity. These γ-AApeptides are active against both Gram-positive and Gram-negative bacteria, including medicinally relevant drug-resistant pathogens. They are believed to exert bactericidal function by mimicking the membrane disruption mechanism of host-defense peptides. As such, they may provide an alternative approach for antimicrobial development combating antibiotic resistance.

Keywords:

• antimicrobial
• Gram-positive and Gram-negative
• membrane disruption
• peptidomimetics
• γ-AApeptides

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Notes